WO2002024230A1 - Solid preparations - Google Patents
Solid preparations Download PDFInfo
- Publication number
- WO2002024230A1 WO2002024230A1 PCT/JP2001/008264 JP0108264W WO0224230A1 WO 2002024230 A1 WO2002024230 A1 WO 2002024230A1 JP 0108264 W JP0108264 W JP 0108264W WO 0224230 A1 WO0224230 A1 WO 0224230A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solid preparations
- active substance
- physiologically active
- granules
- cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/380,725 US20040034039A1 (en) | 2000-09-22 | 2001-09-21 | Solid preparations |
| AU2001288102A AU2001288102A1 (en) | 2000-09-22 | 2001-09-21 | Solid preparations |
| EP01967797A EP1319409A4 (en) | 2000-09-22 | 2001-09-21 | SOLID PREPARATIONS |
| CA002423329A CA2423329A1 (en) | 2000-09-22 | 2001-09-21 | Solid preparations |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-289345 | 2000-09-22 | ||
| JP2000289345 | 2000-09-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2002024230A1 true WO2002024230A1 (en) | 2002-03-28 |
Family
ID=18772770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2001/008264 Ceased WO2002024230A1 (en) | 2000-09-22 | 2001-09-21 | Solid preparations |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040034039A1 (ja) |
| EP (1) | EP1319409A4 (ja) |
| AU (1) | AU2001288102A1 (ja) |
| CA (1) | CA2423329A1 (ja) |
| WO (1) | WO2002024230A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003064429A1 (en) * | 2002-01-30 | 2003-08-07 | Takeda Chemical Industries, Ltd. | Thienopyrimidines, process for preparing the same and use thereof |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100891887B1 (ko) | 2001-01-29 | 2009-04-03 | 시오노기세이야쿠가부시키가이샤 | 5-메틸-1-페닐-2-(1h)-피리돈을 활성 성분으로서 함유하는의약 제제 |
| US7300935B2 (en) | 2003-01-29 | 2007-11-27 | Takeda Pharmaceutical Company | Thienopyrimidine compounds and use thereof |
| KR100882156B1 (ko) | 2003-08-08 | 2009-02-06 | 아지노모토 가부시키가이샤 | 나테글리니드 함유 제제 |
| ES2655435T3 (es) | 2003-09-12 | 2018-02-20 | Amgen Inc. | Formulación de disolución rápida de cinacalcet |
| US8513261B2 (en) * | 2009-03-13 | 2013-08-20 | Toyama Chemical Co., Ltd. | Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995022981A1 (en) * | 1994-02-24 | 1995-08-31 | Nippon Chemiphar Co., Ltd. | Oral synthetic peptide preparation |
| WO1997040846A1 (en) * | 1996-04-30 | 1997-11-06 | Takeda Chemical Industries, Ltd. | COMBINED USE OF GnRH AGONIST AND ANTAGONIST |
| JPH1045619A (ja) * | 1996-07-31 | 1998-02-17 | Kaken Pharmaceut Co Ltd | 成長ホルモン分泌促進ペプチド含有経口製剤 |
| WO2000000493A1 (en) * | 1998-06-26 | 2000-01-06 | Takeda Chemical Industries, Ltd. | Thienopyridine compounds, their production and use |
| WO2000056739A1 (en) * | 1999-03-24 | 2000-09-28 | Takeda Chemical Industries, Ltd. | Thienopyrimidine compounds, their production and use |
| WO2001012193A1 (en) * | 1999-08-16 | 2001-02-22 | Schering Aktiengesellschaft | Pharmaceutical agent comprising a benzamide derivative as active ingredient |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5921613A (ja) * | 1982-07-28 | 1984-02-03 | Takeda Chem Ind Ltd | 直腸投与製剤 |
| US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
| US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| US5155115A (en) * | 1991-03-12 | 1992-10-13 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
| TW449600B (en) * | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
| MX9706062A (es) * | 1995-02-08 | 1997-10-31 | Yamanouchi Europ Bv | FORMAS DE DOSIFICACION ORAL CONTENIENDO UN ANTIBIOTICO DE beta -LACTAMA. |
| EP0781774B1 (en) * | 1995-12-08 | 2002-07-31 | Takeda Chemical Industries, Ltd. | Prolactin production inhibitory agents |
| CA2250895A1 (en) * | 1996-04-26 | 1997-11-06 | Takeda Chemical Industries, Ltd. | Thienopyridine derivatives, their production and use |
| US6313301B1 (en) * | 1997-08-13 | 2001-11-06 | Takeda Chemical Industries, Ltd. | Thienopyridine derivatives, their intermediates and production thereof |
| AU5026599A (en) * | 1998-07-23 | 2000-02-14 | Novo Nordisk A/S | A wet granulation method for preparing a stable pharmaceutical formulation |
| WO2001078780A1 (en) * | 2000-04-13 | 2001-10-25 | Takeda Chemical Industries, Ltd. | Preventives/remedies for alzheimer's disease |
-
2001
- 2001-09-21 EP EP01967797A patent/EP1319409A4/en not_active Withdrawn
- 2001-09-21 CA CA002423329A patent/CA2423329A1/en not_active Abandoned
- 2001-09-21 WO PCT/JP2001/008264 patent/WO2002024230A1/ja not_active Ceased
- 2001-09-21 US US10/380,725 patent/US20040034039A1/en not_active Abandoned
- 2001-09-21 AU AU2001288102A patent/AU2001288102A1/en not_active Abandoned
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995022981A1 (en) * | 1994-02-24 | 1995-08-31 | Nippon Chemiphar Co., Ltd. | Oral synthetic peptide preparation |
| WO1997040846A1 (en) * | 1996-04-30 | 1997-11-06 | Takeda Chemical Industries, Ltd. | COMBINED USE OF GnRH AGONIST AND ANTAGONIST |
| JPH1045619A (ja) * | 1996-07-31 | 1998-02-17 | Kaken Pharmaceut Co Ltd | 成長ホルモン分泌促進ペプチド含有経口製剤 |
| WO2000000493A1 (en) * | 1998-06-26 | 2000-01-06 | Takeda Chemical Industries, Ltd. | Thienopyridine compounds, their production and use |
| WO2000056739A1 (en) * | 1999-03-24 | 2000-09-28 | Takeda Chemical Industries, Ltd. | Thienopyrimidine compounds, their production and use |
| WO2001012193A1 (en) * | 1999-08-16 | 2001-02-22 | Schering Aktiengesellschaft | Pharmaceutical agent comprising a benzamide derivative as active ingredient |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP1319409A4 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003064429A1 (en) * | 2002-01-30 | 2003-08-07 | Takeda Chemical Industries, Ltd. | Thienopyrimidines, process for preparing the same and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1319409A4 (en) | 2006-05-03 |
| EP1319409A1 (en) | 2003-06-18 |
| AU2001288102A1 (en) | 2002-04-02 |
| CA2423329A1 (en) | 2003-03-20 |
| US20040034039A1 (en) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2322315A1 (en) | Fast disintegrating tablets | |
| NZ512692A (en) | Sulphoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations | |
| ZA994470B (en) | Use of a polymer of acrylic type as a disintegration agent. | |
| EP1334728A3 (en) | Antithrombotic agents | |
| HUP1300117A2 (en) | Pharmaceutical formulations for dry powder inhalers in the form of hard pellets | |
| MXPA03005893A (es) | Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina. | |
| WO2002019981A3 (en) | Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use | |
| ZA200305315B (en) | Aqueous gel comprising a gelling agent such as kappa carrageenan and at least 85% water. | |
| MY135183A (en) | Rapidly disintegrating methylcellulose tablets | |
| HUP0302508A3 (en) | Pyridazinones and triazinones and their use as active ingredients of pharmaceutical compositions | |
| WO2002024230A1 (en) | Solid preparations | |
| ATE201714T1 (de) | Sprengmittelgranulat enthaltende waschmitteltabletten | |
| WO2002056881A8 (fr) | Comprimes de fenofibrate | |
| AU2002258002A1 (en) | A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising microcrystalline cellulose | |
| AU2001232348A1 (en) | Sustained release preparations of physiologically active compound hardly solublein water and production process and use of the same | |
| CA2390092A1 (en) | Solid dispersion pharmaceutical formulations | |
| EP0972825A3 (en) | Pellet formulations | |
| AU3706999A (en) | Controlled release tablet produced from linear water-insoluble polysaccharides | |
| ATE262318T1 (de) | Eine wasserlösliche verbindung und cellulose enhaltende granulate | |
| CA2411685A1 (en) | Optimised pellet formulations | |
| AU2663800A (en) | Use of natural substances to prevent the leaching of agrochemical active ingredients | |
| JPH1045619A5 (ja) | ||
| WO2002072064A3 (en) | Granular composition comprising an active compound and a cellulose ether and the use thereof | |
| WO2001030324A3 (de) | Verwendung von acetylsalicylsäure sowie zubereitung zur behandlung von prostatahyperplasie | |
| WO2005009395A3 (en) | Cellulosic fiber containing composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2001967797 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2423329 Country of ref document: CA |
|
| WWP | Wipo information: published in national office |
Ref document number: 2001967797 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 10380725 Country of ref document: US |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |